Anna Ratka, Ph.D., Pharm.D., RPh, CPE, is a Professor and Chair of the Department of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). Dr. Ratka graduated with M.S. in pharmacy (1981) and Ph.D. in pharmacology (1985) from Poznan University of Medical Sciences, Poland, and with Pharm.D. from Idaho State University (2000). She completed two post-doctoral fellowships, in neuropharmacology at Rudolf Magnus Institute for Pharmacology at the University of Utrecht, the Netherlands (1985-1988), and in neuroendocrinology at the University of Florida in the Department of Pharmacodynamics (1988-1991). In 1992, she became a faculty member at the College of Pharmacy at Idaho State University (ISU). While at ISU, she completed sabbatical training on cancer pain management at Huntsman Cancer Institute at the University of Utah. In 2003, she joined the Department of Pharmacology and Neuroscience at University of North Texas Health Science Center and served as a founding Director of Clinical Research at the Institute for Aging and Alzheimer’s Disease Research. In 2006, she joined Texas A&M Health Science Center as a founding chair of the Department of Pharmaceutical Sciences and made contributions to development and accreditation of Irma Lerma Rangel College of Pharmacy. In 2013, Dr. Ratka came to Chicago State University College of Pharmacy as chair of the Department of Pharmaceutical Sciences. Dr. Ratka is a Certified Pain Educator. She is a board-certified pharmacist with experience in community and hospital pharmacy practice. Dr. Ratka is a graduate from the American Association of Colleges of Pharmacy Academic Leadership Fellows Program. As a pharmacy faculty, Dr. Ratka has taught and mentored pharmacy professional students and graduate students, conducted research/scholarship, and has been engaged in service to the community and national professional organizations.
Dr. Ratka’s teaching expertise is in pharmacology, pain pharmacotherapy and pain management, basic pharmacokinetics, and compounding of sterile preparations. She is engaged in scholarship of teaching. Dr. Ratka research expertise is in neuroscience/neuropharmacology with special emphasis on pain. In her research she has designed and performed basic and clinical studies. Her current research focus is on the effects of oxidative damage, neuronal degeneration and aging on opioid receptors and pain-relieving effects of opioids. Dr. Ratka has authored about 100 peer-reviewed papers, chapters, and presentations, is a peer-reviewer for several scientific journals and funding agencies, and serves on editorial boards. She received awards for teaching and research from her students and peers.
Currently, Dr. Ratka is a member of the American Association of Colleges of Pharmacy (AACP), American Pharmacists Association (APhA), American Pain Society (APS), American Society of Pain Educators (ASPE), and pharmacy honor societies Phi Delta Chi Pharmacy Fraternity, Rho Chi Honor Society, and Phi Lambda Sigma Pharmacy Leadership Society. At the AACP, she has held leadership positions at the Global Pharmacy Education Special Interest Group, and is a member of the faculty Affairs Committee at the Council of Faculties. She serves as the on-site team evaluator for the Accreditation Council for Pharmacy Education.
Ehab A. Abourashed, M.S., Ph.D., is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP) and is a graduate of the Faculty of Pharmacy, Cairo University, Egypt. He has a Master's Degree in Organic Chemistry from the University of Tennessee, and a Ph.D. in Pharmacognosy from the University of Mississippi. Before joining CSU, Dr. Abourashed was a Lecturing Postdoctoral Research Associate at the University of Mississippi School of Pharmacy; a Senior Research Scientist at GlaxoSmithKline, New Jersey; Associate Professor of Pharmacognosy at King Saud University, Riyadh; and Director of Quality Assurance at ElSohly Labs, Inc. in Mississippi. Dr. Abourashed is also an Adjunct Research Associate Professor at the University of Mississippi’s National Center for Natural Products Research (NCNPR).
Dr. Abourashed's research interests include isolation, structure elucidation and microbial transformation of biologically active natural products; phyto/bioanalytical method development; and phytopharmacology of medicinal plants and herbal dietary supplements. Dr. Abourashed is currently investigating the psychopharmacology of nutmeg, the biological activities of milk thistle, and the antitubercular potentiating properties of selected natural phenolics and sesquiterpenes.
Dr. Abourashed is a member of the American Society of Pharmacognosy, The American Association of Colleges of Pharmacy, the Rho Chi Pharmacy Honor Society and the Phi Kappa Phi Honor Society. His name is also included in Who’s Who in the World 2006. Dr. Abourashed has published more than 30 research papers in peer reviewed journals and is a regular reviewer for the Journal of Natural Products, Planta Medica, Chromatographia and many others. He is also the coauthor of the 3rd edition of ‘Leung’s Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics’. Additional information at http://www.linkedin.com/in/abourashed.
Michael Bradaric, PhD, is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP).
Dr. Bradaric graduated from Lewis University, Romeoville, IL with a BS in Biology and a minor in Chemistry in 2004. He obtained his PhD in Pharmacology at Rush University Medical Center, Chicago, IL in 2011. Prior to CSU, Dr. Bradaric completed a post-doctoral fellowship at the University of Chicago in the department of Obstetrics and Gynecology.
Dr. Bradaric’s research interests have been in multi-disciplinary fields pertaining to the study of ovarian cancer. Previous work involved identifying new clinical targets based on pathological assessment of human tissue, comparative studies using animal models of ovarian cancer (chicken and mouse), and the use of human ovarian cancer cells to screen novel drugs for anti-proliferative efficacy. Dr. Bradaric is currently examining the role of the tumor cytokine signaling network, and the pharmacological targeting of the cross-talk between cells of the immune system and the developing tumor. His research achievements in these areas are documented in several peer-reviewed journal articles in the ovarian cancer literature and in numerous poster presentations. Cross-institutional studies are geared toward early diagnosis and chemoprevention.
Dr. Bradaric has lectured physiology and pharmacology courses, and has clinical pharmacy and autopsy experience. Dr. Bradaric is a member of the American Association for Cancer Research (AACR), the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Michael Danquah, M.S., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He obtained his Bachelors in Chemical Engineering from Kwame Nkrumah University of Science and Technology, Ghana. Dr. Danquah has a Master’s Degree in Chemical Engineering from the University of Kentucky, and a Ph.D. in Pharmaceutics and Drug Delivery from the University of Tennessee Health Science Center.
Dr. Danquah’s research interests include: (i) Design and synthesis of novel biodegradable polymers for controlled drug and nucleic acid delivery, (ii) Nano based combination therapy for treating cancer, (iii) Design and construction of novel bipartite shRNA expressing plasmids for cancer therapy, (iv) Formulation, delivery, in vitro and in vivo characterization of siRNA and shRNA for treating cancer and (v) Application of stem cells and biomaterials for tissue regeneration and repair. His research accomplishments in these areas are documented in published peer-reviewed journal articles. Dr. Danquah also serves as a regular reviewer for Pharmaceutical Research and Advanced Drug Delivery Reviews and is a member of the American Association of Colleges of Pharmacy (AACP), the American Association of Pharmaceutical Scientists (AAPS), and the Controlled Release Society (CRS).
Duc P. Do, Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). Prior to joining CSU-COP, Dr. Do was Assistant Professor of Pharmaceutical Sciences at Lake Erie College of Osteopathic Medicine (LECOM), School of Pharmacy. He received his B.S. from the University of Georgia and his Ph.D. in Pharmaceutical Sciences (Pharamceutics) from Mercer University, College of Pharmacy & Health Sciences. His research interests are in the areas of drug delivery systems, dosage form formulation, and microencapsulation technology. Dr. Do has published several peer-reviewed journal articles in these areas. He is copy editor for the journal European Journal of Chemistry and has served as a reviewer for several scientific journals.
Dr. Do is a member of several scientific and professional organizations, including the Rho Chi Pharmacy Honor Society, the American Association of Colleges of Pharmacy (AACP), the American Association of Pharmaceutical Scientists (AAPS), and the American Association for Cancer Research (AACR).
Abir El-Alfy, B. Pharm., M.S., Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP) and is a graduate of the Faculty of Pharmacy, Cairo University, Egypt. She has a Master's Degree in Microbiology from the University of Mississippi, and a Ph.D. in Pharmacology and Toxicology from the University of Mississippi. Before joining CSU, Dr. El-Alfy was an Assistant Professor of Pharmacology, as well as the Director of the Behavioral Neuroscience Core-NPN at the School of Pharmacy, University of Mississippi.
Dr. El-Alfy's research interest fall in two categories: 1) establishing the molecular mechanisms underlying the neurotoxicity of acrylamide in both young and adult animal models and 2) understanding the role of the endocannabinoid system in neuropsychiatric disorders as depression, anxiety, and posttraumatic disorder. The ultimate goal of his research is to develop novel drugs that prevent/treat the acrylamide-induced neurotoxicity as well as develop new therapeutic targets for the treatment of neuropsychiatric disorders.
Dr. El-Alfy has been teaching in Pharmacy Schools for over 10 years. Her teaching experiences span basic physiology and biochemistry to pharmacology and toxicity, clinical pharmacology and toxicology, as well as advance graduate courses.
Dr. El-Alfy's is a member of The American Association of Colleges of Pharmacy, The American Society of Pharmacology and Experimental Therapeutics, the American Society of Pharmacognosy, the Rho Chi Pharmacy Honor Society, and the Phi Kappa Phi Honor Society. Dr. El-Alfy has published more than 20 research papers in peer reviewed journals and is a regular reviewer for the Journal of Diabetes Complications, Planta Medica, Journal of Advanced Research, and many others. She holds one patent on developing indole compounds as antidepressant medication, and another patent is currently under review. Dr. El-Alfy has presented her research extensively in regional, national, as well as international meetings. She has won several awads including a small NIH grant to examine the neurotoxic effects of acrylamide as well as an NIH COBRE junior investigator grant to examine the mechanism of antidepressant action of cannabinoids.
Nadeem Fazal, M.D, Ph.D. is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He received his MD from King Edward Medical University, Lahore, Pakistan, and PhD in Immunology from The University of Birmingham, England, United Kingdom. He is a member of American Association for Immunologists (AAI) and American Society for Microbiology (ASM). He completed his Post-doctoral training, Fellowship and later served as faculty at Stritch School of Medicine Loyola University Chicago. Dr. Fazal began his teaching career at the Department of Microbiology and Immunology, Rawalpindi Medical College, The University of Punjab, Lahore. He also served as faculty at Chicago State University Department of Biological Sciences. He has received President’s and Young Scientist Award from Societies of General Microbiology (SGM), American Society for Microbiology (ASM) and British Society for Immunology (BSI). He was also a recipient of Rowtham Bequest Award from The University of Birmingham, England, United Kingdom. His research interests include investigating mechanisms of cellular immune responses to acute injury/infection and pharmacological agents modulating such host responses. He has published more than 30 papers in peer-reviewed scientific journals. Dr. Fazal is a member of numerous scientific and professional organizations, including, The American Physiological Society (APS), The American Society of Human Genetics (ASHG), and The American Association of Colleges of Pharmacy (AACP).
Mohammad Newaz MD, Ph.D., is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). Before joining CSU Dr. Newaz was Associate Professor / senior Scientist and Head of Hypertension Unit in the Center for Cardiovascular Diseases, Texas Southern University, Houston, Texas. Dr. Newaz received his MD from University of Chittagong, Bangladesh (1992) and PhD from the National University of Malaysia (1998). He has held faculty positions at the University of Science and Technology Chittagong, Bangladesh, National University of Malaysia and International Islamic University Malaysia before joining the Center for Cardiovascular Diseases in 2000. His research focus is primarily on hypertension and vascular physiology using integrated investigative approach with special emphasis on understanding molecular events contributing to the pathogenesis of hypertension and its complications.
Dr. Newaz is a member of many professional societies, including the American Heart Association, American Physiological Society. He has received numerous honors and awards, including the Young Investigator Award from High Blood Pressure Council of American Heart Association, Young Investigator Award from the renal section of The American Physiological Society, Caroline Tun Suden professional opportunity award from The American Physiological Society, Young Investigator Award from The International Society of Hypertension, FASEB MARC fellowship and Grant-in-Aid from American Heart Association. He has published more than 30 peer reviewed research paper in high impact journals, book chapters and invited reviews in the field of hypertension and vascular biology. Dr. Newaz presented his research works extensively at conferences locally and internationally and was also an invited speaker in several Universities in the US.
Melany P. Puglisi, Ph.D. is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). She received her B.A. in chemistry from Southampton College, now part of Long Island University, in 1991. Her graduate studies were carried out at University of Guam where she received her M.S. in Biology in 1995 and the University of Mississippi, School of Pharmacy where she received her Ph.D. in pharmacognosy. She received grants from the American Museum of Natural History and the Australian Museum of Natural History to conduct her research on Guam and the Great Barrier Reef (Lizard Island).
Prior to joining CSU she conducted post-doctoral research at Scripps Institution of Oceanography at the University of California at San Diego, the Smithsonian Marine Station at Fort Pierce, and Shannon Point Marine Station at Western Washington University. Dr. Puglisi’s research interests include marine natural products and chemical ecology of algae and marine invertebrates. She has participated in numerous research expeditions in the tropical Atlantic and Pacific including the 2005 NOAA Florida Coast Deep Corals research cruise.
Dr. Puglisi is a member of several scientific and professional organizations including the American Association of Colleges of Pharmacy (AACP) and the American Society of Pharmacognosy. She has served as chair of the Younger Members Committee of the ASP. Dr. Puglisi has received awards throughout her academic career that not only recognize her research achievements but also highlight her service to the community.
Jozef Stec, Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP).
He received his M.Sc. (with Honors) in Molecular and Pharmaceutical Biotechnology from Gdansk University of Technology, Poland, and Ph.D. in Organic Chemistry from the University of Southampton, U.K. Before joining CSU, Dr. Stec completed postdoctoral training in Synthetic Medicinal Chemistry at the University of Illinois, Chicago.
Dr. Stec’s research interests are in the field of widely understood synthetic organic and modern medicinal chemistry. He is especially interested in synthetic innovation by designing and inventing new reactions, developing them into powerful methodologies with the aim of their subsequent application to total syntheses of biologically active natural products along with their analogs as the starting point for successful lead generation in various drug discovery programs. Dr. Stec’s research efforts in modern medicinal chemistry are directed towards discovery of new antiprotozoal and antibacterial agents through rational design and synthesis. This work involves selecting new molecular targets, structure-based design and subsequent synthesis of small molecules, which have the potential for therapeutic utility as well as serve as chemical tools to investigate the biological functions of the molecular targets.
His research achievements in these areas are documented in several peer-reviewed journal articles.
Dr. Stec is a member of the American Association of Pharmaceutical Scientists (AAPS) and the American Association for the Advancement of Science (AAAS).
During his academic career, Dr. Stec has also been teaching for several years the principles of organic and medicinal chemistry as well as mentoring students at undergraduate and postgraduate level.
Vera Lynn Hilliard is the Pharmacy Laboratory Support Specialist for Chicago State University College of Pharmacy (CSU-COP). Ms. Hilliard received her Bachelors Degree in Chemistry from Southeast Missouri State University (2006). Joining the staff of CSU in 2008, Ms. Hilliard is responsible for the daily maintenance and operations of the Student Practice Lab.
Prior to joining Chicago State University, Ms. Hilliard was a science teacher for the Ferguson Florissant School District in Missouri. With over ten years of healthcare and higher education experience, she has been a PTCB Certified Pharmacy Technician for four years.
Daniel W. Pietryla is the Research Laboratory Technician Specialist for Chicago State University College of Pharmacy (CSU-COP). Mr. Pietryla received his Bachelors Degree in Biology from The University of Chicago (1983). Mr. Pietryla is the Lab Manager for the Pharmaceutical Sciences Research Facility.
Before joining the College of Pharmacy at CSU in 2012, Mr. Pietryla was a Research Assistant in the Departments of Biochemistry and Orthopedics at Rush University Medical Center in Chicago. In a career in basic research spanning 27 years, Mr. Pietryla has contributed to, as Co-Author, 6 major publications and 29 scientific abstracts in topics ranging from joint inflammation to intervertebral disc degradation and repair. Mr. Pietryla brings a diverse technical skills set in biochemical, histological, immunological, surgical, and clinical protocols and methodologies to the Pharmaceutical Sciences Research Lab. Additional information at http://www.linkedin.com/pub/dan-pietryla/39/4a8/331.